BROWN CAPITAL MANAGEMENT INC 13D and 13G filings for Cytek Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:42 pm Sale |
2024-09-30 | 13G | Cytek Biosciences, Inc. CTKB |
BROWN CAPITAL MANAGEMENT INC | 9,493,474 7.220% |
-2,522,851 (-21.00%) |
Filing |
| 2024-02-14 3:12 pm Purchase |
2023-12-31 | 13G | Cytek Biosciences, Inc. CTKB |
BROWN CAPITAL MANAGEMENT INC | 12,016,325 8.860% |
12,016,325 (New Position) |
Filing |